Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery
- Conditions
- Interventions
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2012-01-06
- Lead Sponsor
- University of Parma
- Target Recruit Count
- 22
- Registration Number
- NCT00681174
- Locations
- 🇮🇹
University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy
Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2017-08-07
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 56
- Registration Number
- NCT00672737
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Effects of Remifentanil on Respiratory Function in Mechanically Ventilated Patients
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2008-12-18
- Lead Sponsor
- Fondazione Poliambulanza Istituto Ospedaliero
- Target Recruit Count
- 14
- Registration Number
- NCT00665119
- Locations
- 🇮🇹
Intensive Care Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG)
- Conditions
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 10
- Registration Number
- NCT00641563
- Locations
- 🇨🇭
Departement of Intensive Care Medicine - University Hospital Bern - Inselspital, Bern, Switzerland
Effect of Thoracic Epidural Analgesia on Intravenous Closed-Loop Anesthesia
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2016-09-23
- Lead Sponsor
- Hopital Foch
- Target Recruit Count
- 40
- Registration Number
- NCT00627081
- Locations
- 🇫🇷
Hôpital Foch, Suresnes, France
Intravenous Versus Inhalational Anesthesia in Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2015-07-13
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 58
- Registration Number
- NCT00615472
- Locations
- 🇺🇸
Columbia Unviversity, Deparment of Anesthesiology, New York, New York, United States
Changes of the Neuronal Activity in the Subthalamic Nucleus Under Remifentanil Sedation During Stereotactic Electrode Implantation
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2008-01-09
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT00588926
Remifentanil for General Anesthesia in Preeclamptics
- Conditions
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2007-12-05
- Lead Sponsor
- Istanbul University
- Target Recruit Count
- 50
- Registration Number
- NCT00567957
- Locations
- 🇹🇷
Istanbul University, Istanbul Faculty of Medicine Anesthesiology Dept., Istanbul, Capa, Turkey
Anesthetics and Auditory, Visceral, and Heat Evoked Potentials
- Conditions
- Interventions
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2007-09-26
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 60
- Registration Number
- NCT00534586
- Locations
- 🇩🇪
Technische Universität München, Klinikum rechts der Isar, Department of Anesthesiology, Munich, Bavaria, Germany
Optimum Dose of Remifentanil for Intubation in Small Children
- Conditions
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 60
- Registration Number
- NCT00474071
- Locations
- 🇨🇦
BC Children's Hospital, Vancouver, British Columbia, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.